We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current MYX market cap is 363.27M. The company's latest EPS is AUD -2.0480 and P/E is -2.08.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 456.99M | 400.78M | 400.93M | 262.48M | 386.19M |
| Operating Income | -104.12M | -230.15M | -11.86M | -233.15M | -171.6M |
| Net Income | -92.79M | -208.42M | -281.29M | 117.25M | -174.23M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 1.83B | 1.46B | 1.29B | 1.25B | 1.14B |
| Total Liabilities | 782.87M | 691.61M | 749.7M | 612.99M | 688.99M |
| Total Equity | 1.04B | 771.58M | 538.23M | 634.36M | 454.19M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | 99.78M | 58.86M | -7.21M | -42.71M | -15.3M |
| Investing | -55.87M | -49.25M | -28.53M | 473.49M | 53.45M |
| Financing | 4.52M | -40.44M | 27.6M | -431.89M | -19.85M |
| Market Cap | 363.27M |
| Price to Earnings Ratio | -2.08 |
| Price to Sales Ratio | 0.94 |
| Price to Cash Ratio | 3.3 |
| Price to Book Ratio | 0.8 |
| Dividend Yield | - |
| Shares Outstanding | 85.07M |
| Average Volume (1 week) | 142.5k |
| Average Volume (1 Month) | 173.58k |
| 52 Week Change | -7.78% |
| 52 Week High | 7.46 |
| 52 Week Low | 3.74 |
| Spread (Intraday) | 0.26 (6.09%) |
| Company Name | Mayne Pharma Group Ltd |
| Address |
1538 main north road adelaide, south australia 5106 |
| Website | https://www.maynepharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
